To advance the timeline of market-entry for a drug intended to provide symptom relief of an overactive bladder (OAB), 1nHealth is seeking out men undergoing treatment for Benign Prostatic Hyperplasia (BPH). Participants will contribute to the verification of the drug’s safety, efficacy, and tolerability.
Background Information
A staggering 30 percent of men in the U.S. suffer from OAB symptoms. Given the prevalence of the condition and the number of symptoms it shares with BPH, it’s worth examining the effectiveness of a novel treatment option among men undergoing pharmacological therapy for BPH.
Here is a breakdown of OAB and BPH symptoms, including those they share (in bold):
Current treatment options consist of lifestyle changes (improved diet/weight loss, Kegel exercises), nerve stimulation, bladder injections, and as a last resort – surgery.
Impact on Quality of Life
The symptoms of OAB can be quite uncomfortable. Moreover, the fear of not having immediate access to a bathroom can take a toll on one’s quality of life. It’s not uncommon for an individual suffering from these symptoms, without access to a proper treatment option, to avoid going out in public. An interrupted sleep cycle and a negative impact on one’s sex life are also very real implications of OAB symptoms, which can lead to bouts of depression and/or anxiety.
Study Specifics
Recruitment for this clinical trial currently calls for male participants, age 45+, living within a 25-mile radius of San Diego, CA. Compensation is available for those who complete the clinical trial while demonstrating protocol compliance.
Applying to the study is straightforward, quick, and painless. All you’ll need is access to a reliable internet connection in order to register and complete a brief survey. If you qualify, a member of our study team will contact you to schedule a visit to your nearest clinic location.
